Downloadable Slides

Share

Program Content

Activities

  • Evidence for SERDs Tx
    The Expanding Evidence Base for Oral SERDs and Other ER-Targeting Agents
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

  • Future for SERD Tx
    Possibilities for the Future of SERD Therapy for HR+/HER2- Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

  • SERD for ET Resistance
    Steps Toward Precision Oncology: Role of SERD in Attacking Endocrine Resistance in HR+/HER2- Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Lilly.

AstraZeneca

Lilly